Cipla Limited (BOM:500087)

India · Delayed Price · Currency is INR

1,343.00

+9.00 (0.67%)

At close: Oct 6, 2026

Cipla Employees

Cipla had 31,369 employees as of March 31, 2026. The number of employees increased by 1,056 or 3.48% compared to the previous year.

Employees

31,369

Change (1Y)

1,056

Growth (1Y)

3.48%

Revenue / Employee

8.95M INR

Profits / Employee

1.07M INR

Market Cap

1.08T

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2026	31,369	1,056	3.48%
Mar 31, 2025	30,313	2,549	9.18%
Mar 31, 2024	27,764	-4,559	-14.10%
Mar 31, 2023	32,323	6,396	24.67%
Mar 31, 2022	25,927	255	0.99%
Mar 31, 2021	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
Dr. Reddy's Laboratories	27,527
Lupin	26,021
Torrent Pharmaceuticals	18,258
Jubilant Pharmova	5,657
J. B. Chemicals & Pharmaceuticals	5,602
Granules India	4,306
Caplin Point Laboratories	4,199
Abbott India	3,679

Employee Rankings

Cipla News

4 days ago - FDA cancels Pune Cipla facility's drug sale and distribution licences - The Times of India
5 days ago - Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations' - NDTV
4 weeks ago - India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - Reuters
5 weeks ago - ‘You’re going overboard’: Bombay high court to FDA, restores Cipla’s licence - The Times of India
5 weeks ago - After Bombay HC rap, FDA withdraws orders against Cipla, MCA eateries - The Times of India
5 weeks ago - Maharashtra FDA cancels Cipla unit’s drug sale licences in Pune - The Times of India
5 weeks ago - Maharashtra FDA cancels Pune Cipla facility’s sale licences over ‘lapses’ - The Times of India
5 weeks ago - Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations - The Times of India